4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-009238
Options or other derivatives
- Chief Medical Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KENNEY CHRISTOPHER JOHN · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-09 | Grant or award : show line 1 in the form Share Option (Right to Buy) | +100,000 | 100,000 | D |
| 2026-01-09 | Grant or award : show line 2 in the form Restricted Share Units | +20,000 | 20,000 | D |
Loading xslF345X05/ownership.xml…